Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Strong expression of GATA3 and ER in a majority of primary node-positive ductal breast cancer was corroborated by quantitative RT-PCR and immunohistochemistry in the initial sample set, and by immunohistochemistry in an additional set from 167 patients diagnosed of node-negative and -positive primary infiltrating ductal breast cancer, including 102 samples from loco-regional lymph node metastases matched to their primary tumors, as well as 37 distant metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Strong expression of GATA3 and ER in a majority of primary node-positive ductal breast cancer was corroborated by quantitative RT-PCR and immunohistochemistry in the initial sample set, and by immunohistochemistry in an additional set from 167 patients diagnosed of node-negative and -positive primary infiltrating ductal breast cancer, including 102 samples from loco-regional lymph node metastases matched to their primary tumors, as well as 37 distant metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Strong expression of GATA3 and ER in a majority of primary node-positive ductal breast cancer was corroborated by quantitative RT-PCR and immunohistochemistry in the initial sample set, and by immunohistochemistry in an additional set from 167 patients diagnosed of node-negative and -positive primary infiltrating ductal breast cancer, including 102 samples from loco-regional lymph node metastases matched to their primary tumors, as well as 37 distant metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP383902.RAeuOLzSXYBAhImUyDL3cyhAz7yE8WP8_HA7UiATW4HCM130_assertion description "[Strong expression of GATA3 and ER in a majority of primary node-positive ductal breast cancer was corroborated by quantitative RT-PCR and immunohistochemistry in the initial sample set, and by immunohistochemistry in an additional set from 167 patients diagnosed of node-negative and -positive primary infiltrating ductal breast cancer, including 102 samples from loco-regional lymph node metastases matched to their primary tumors, as well as 37 distant metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP383902.RAeuOLzSXYBAhImUyDL3cyhAz7yE8WP8_HA7UiATW4HCM130_provenance.
• NP1126273.RApZ0fWM7JEjuv6q2MpOB-Mb2l2BEstwZMmwALR5gGZIA130_assertion description "[Strong expression of GATA3 and ER in a majority of primary node-positive ductal breast cancer was corroborated by quantitative RT-PCR and immunohistochemistry in the initial sample set, and by immunohistochemistry in an additional set from 167 patients diagnosed of node-negative and -positive primary infiltrating ductal breast cancer, including 102 samples from loco-regional lymph node metastases matched to their primary tumors, as well as 37 distant metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126273.RApZ0fWM7JEjuv6q2MpOB-Mb2l2BEstwZMmwALR5gGZIA130_provenance.
• NP419180.RAP2Malp4G7S-fKFWUmvmTQCS42U2Ebmn_LyAEWNs6yqk130_assertion description "[Strong expression of GATA3 and ER in a majority of primary node-positive ductal breast cancer was corroborated by quantitative RT-PCR and immunohistochemistry in the initial sample set, and by immunohistochemistry in an additional set from 167 patients diagnosed of node-negative and -positive primary infiltrating ductal breast cancer, including 102 samples from loco-regional lymph node metastases matched to their primary tumors, as well as 37 distant metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419180.RAP2Malp4G7S-fKFWUmvmTQCS42U2Ebmn_LyAEWNs6yqk130_provenance.
• NP419200.RAM-gVs1GCCev4v0m76eGbiFGXTU3qfGOGM7nS8Cyl3-E130_assertion description "[Strong expression of GATA3 and ER in a majority of primary node-positive ductal breast cancer was corroborated by quantitative RT-PCR and immunohistochemistry in the initial sample set, and by immunohistochemistry in an additional set from 167 patients diagnosed of node-negative and -positive primary infiltrating ductal breast cancer, including 102 samples from loco-regional lymph node metastases matched to their primary tumors, as well as 37 distant metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419200.RAM-gVs1GCCev4v0m76eGbiFGXTU3qfGOGM7nS8Cyl3-E130_provenance.
• NP419354.RAHIcqehKcp3_v0uP0w1Q4Ewc_v0iXdskPNjazHR23j1M130_assertion description "[Strong expression of GATA3 and ER in a majority of primary node-positive ductal breast cancer was corroborated by quantitative RT-PCR and immunohistochemistry in the initial sample set, and by immunohistochemistry in an additional set from 167 patients diagnosed of node-negative and -positive primary infiltrating ductal breast cancer, including 102 samples from loco-regional lymph node metastases matched to their primary tumors, as well as 37 distant metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419354.RAHIcqehKcp3_v0uP0w1Q4Ewc_v0iXdskPNjazHR23j1M130_provenance.
• NP1126274.RAGl9Y5TubB1r3bq80pxwTygcoUILoB7sEEZSqe4Br8-U130_assertion description "[Strong expression of GATA3 and ER in a majority of primary node-positive ductal breast cancer was corroborated by quantitative RT-PCR and immunohistochemistry in the initial sample set, and by immunohistochemistry in an additional set from 167 patients diagnosed of node-negative and -positive primary infiltrating ductal breast cancer, including 102 samples from loco-regional lymph node metastases matched to their primary tumors, as well as 37 distant metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126274.RAGl9Y5TubB1r3bq80pxwTygcoUILoB7sEEZSqe4Br8-U130_provenance.
• NP1126275.RAPWmq3VHhPPPkk4NKH4HlXWtaTYgtGSlVgfDAnywc7kM130_assertion description "[Strong expression of GATA3 and ER in a majority of primary node-positive ductal breast cancer was corroborated by quantitative RT-PCR and immunohistochemistry in the initial sample set, and by immunohistochemistry in an additional set from 167 patients diagnosed of node-negative and -positive primary infiltrating ductal breast cancer, including 102 samples from loco-regional lymph node metastases matched to their primary tumors, as well as 37 distant metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126275.RAPWmq3VHhPPPkk4NKH4HlXWtaTYgtGSlVgfDAnywc7kM130_provenance.